Ainuomiti Tablets (Anti-HIV/AIDS innovative drug)

Ainuomiti Tablets (Anti-HIV/AIDS innovative drug)
Product Description

Ainuomiti Tablets 

(Ainuovirine, Lamivudine and Tenofovir Disoproxil Fumarate Tablets)

 

The first innovative oral anti-HIV/AIDS single-tablet combination in China, containing key NCE of Ainuovirine. 

Read more Show less

Jiangsu Aidea Pharmaceutical Co.,Ltd.

  • CN
  • 2022
    On CPHI since
  • 1
    Certificates
  • 500 - 999
    Employees
Company types
Distributor/Import Export
Generics/Biosimilars Manufacturer
Manufacturer/Innovator
Primary activities
Pharmaceutical Company (innovator finished products)
View company profile
Categories
more categories Show less
Specifications
  • Supplied from
    China
More specifications Fewer specifications

Jiangsu Aidea Pharmaceutical Co.,Ltd.

  • CN
  • 2022
    On CPHI since
  • 1
    Certificates
  • 500 - 999
    Employees
Company types
Distributor/Import Export
Generics/Biosimilars Manufacturer
Manufacturer/Innovator
Primary activities
Pharmaceutical Company (innovator finished products)
View company profile

More Products from Jiangsu Aidea Pharmaceutical Co.,Ltd. (4)

  • Ulinastatin

    Product Ulinastatin

    1、A natural broad-spectrum proteinase inhibitor extracted from human urine

    2、Block the process of SIRS and MODS

    2、Protect the function of vital organs

  • Urokinase

    Product Urokinase

    1、A kind of zymoprotein extracted from human urine

    2、Activate the endogenous fibrinolysis system and convert plasminogen into plasmin

    3、Favorable ...

  • Sennae Folium Granule

    Product Sennae Folium Granule

    1、A natural botanical drug for the treatment of constipation recommended by the WGO* Guideline

    2、Purge heat, activate stagnation and relax Intestines

    3、An exclusive product with double sales channels of OTC & prescription

     

    *WGO: World Gas...
  • Ainuovirine Tablets (Anti-HIV/AIDS innovative drug)

    Product Ainuovirine Tablets (Anti-HIV/AIDS innovative drug)

    Ainuovirine Tablets

     

    The first innovative Class I anti-HIV/AIDS tablets approved for marketing in China. A new generation of non-nucleoside reverse transcriptase inhibitors (NNRTIs).